Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE4
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients
- Status
- WITHDRAWN
- Phase
- PHASE4
A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment
- Status
- COMPLETED
- Phase
- PHASE4
Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients
- Status
- UNKNOWN
- Phase
- PHASE4
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women
- Status
- COMPLETED
- Phase
- PHASE2
Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Everolimus With and Without Temozolomide in Adult Low Grade Glioma
- Status
- TERMINATED
- Phase
- PHASE2
Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator.
- Status
- COMPLETED
- Phase
- PHASE2
Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors
- Status
- UNKNOWN
- Phase
- NA
A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study
- Status
- UNKNOWN
- Phase
- NA
Everolimus Post Orthotopic Liver Transplant
- Status
- UNKNOWN
- Phase
- PHASE2
Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)
- Status
- WITHDRAWN
- Phase
- PHASE2
Comparing Everolimus and Sirolimus in Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- NA
Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study
- Status
- UNKNOWN
- Phase
- PHASE2
NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2